Trilaciclib dihydrochloride is a pharmaceutical raw material used to reduce the frequency of chemotherapy-induced bone marrow suppression. It is a salt-form compound with a complex heterocyclic structure containing multiple amine and amide functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1977495-97-8
Trilaciclib
active pharmaceutical ingredient
1,3''-Di-HABA Kanamycin A
Aminoglycoside antibiotic impurity
Teduglutide
active pharmaceutical ingredient
3-[(3R,4S)-3,4-dimethylpiperidin-4-yl]phenol
active pharmaceutical ingredient impurity
Picloxydine dihydrochloride
active pharmaceutical ingredient
4-[[5-(4-methylpiperazin-1-yl)-2-pyridinyl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one;dihydrochloride
BRCYOXKEDFAUSA-UHFFFAOYSA-N
CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6.Cl.Cl